Research Overview

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations focused on stem cell therapy -- both allogeneic and autologous. A number of emerging technologies have been discussed for a variety of therapeutic indications including cancer, autoimmune diseases, and neurological disorders. Further, innovations on nucleic acid drugs and novel drug delivery systems have also been covered. Few innovations highlight developments in oral pox drugs, senotherapeutics, and artificial lactoferrin.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.